Early cancer diagnosis and community pharmacies: a systematic review
Robust, large-scale clinical trials are needed to demonstrate cost-effectiveness, delineate and inform the use of relevant clinical outcomes, and to explore arrangements for information sharing between community pharmacy and other healthcare settings.
Authors
- Gary Abel (ORCID: https://orcid.org/0000-0003-2231-5161)
- Rachel Winder (ORCID: https://orcid.org/0000-0002-9926-1280)
- John Campbell (ORCID: https://orcid.org/0000-0002-6752-3493)
- Judit Konya (ORCID: https://orcid.org/0000-0002-8592-9702)
- Michael J. Carter (ORCID: https://orcid.org/0000-0003-3403-4746)
- Richard D Neal (ORCID: https://orcid.org/0000-0002-3544-2744)
- Christopher Elles Clark (ORCID: https://orcid.org/0000-0002-7526-3038)
- David Bearman
- Gianni Dongo
- Ziad Abdussalam Laklouk
Institutions
- University of Exeter (GB)
- Central London Community Healthcare NHS Trust (GB)
- AT&T (United Kingdom) (GB)
- Exeter Primary Care (GB)
- Devon & Exeter Institution (GB)
Publication Details
- Journal
- British Journal of General Practice
- Published
- 2025-09-15
- DOI
- https://doi.org/10.3399/bjgp.2025.0204
- Primary Topic
- Health Sciences Research and Education
- Type
- article
- Field-Weighted Citation Impact
- 0.00